Handelen First Wave BioPharma, Inc. - FWBI CFD
Toevoegen aan favorieten- Samenvatting
- Historische gegevens
- Evenementen
- Winst- en verliesrekening
- Balans
- Cash Flow
- Eigendom
Handelsvoorwaarden
| Spread | 0.1212 | ||||||||
|
Overnight-tarief longpositie
Long position overnight fee
Ga naar platform | -0.024068% | ||||||||
|
Overnight-tarief shortpositie
Short position overnight fee
Ga naar platform | 0.001846% | ||||||||
| Tijd van overnight-tarief | 21:00 (UTC) | ||||||||
| Min. verhandelde hoeveelheid | 0.001 | ||||||||
| Valuta | USD | ||||||||
| Marge | 20% | ||||||||
| Effectenbeurs | United States of America | ||||||||
| Handelscommissie | 0% |
*Information provided by Capital.com
Belangrijkste statistieken
| Prev. Close* | 3.0092 |
| Open* | 3.0188 |
| 1-Jaarlijkse Verandering* | 167.15% |
| Dagelijks bereik* | 2.9692 - 3.0191 |
| 52 wekelijks bereik | 2.76-289.80 |
| Weekgemiddelde volume (10 dagen) | 52.51K |
| Gemiddeld volume (3 maanden) | 11.19M |
| Marktkapitalisatie | 4.82M |
| P/E Ratio | -100.00K |
| Uitstaande Aandelen | 1.55M |
| Omzet | N/A |
| EPS | -248.68 |
| Dividend (opbrengst %) | N/A |
| Beta | 1.69 |
| Volgende inkomsten datum | N/A |
Alle gegevens zijn afkomstig van Refinitiv, behalve de gegevens gemarkeerd met een sterretje, die zijn afkomstig van Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Slotkoers | Change | Change (%) | Openingskoers | High | Low |
|---|---|---|---|---|---|---|
| Mar 24, 2023 | 2.9994 | 0.0199 | 0.67% | 2.9795 | 3.0290 | 2.9692 |
| Mar 23, 2023 | 3.0092 | -0.0587 | -1.91% | 3.0679 | 3.1978 | 2.9791 |
| Mar 22, 2023 | 3.0193 | -0.0990 | -3.17% | 3.1183 | 3.1774 | 2.9687 |
| Mar 21, 2023 | 3.1678 | 0.0892 | 2.90% | 3.0786 | 3.1678 | 3.0582 |
| Mar 20, 2023 | 3.0588 | 0.0499 | 1.66% | 3.0089 | 3.1283 | 2.9691 |
| Mar 17, 2023 | 3.0291 | 0.0600 | 2.02% | 2.9691 | 3.0391 | 2.9591 |
| Mar 16, 2023 | 2.9695 | 0.1986 | 7.17% | 2.7709 | 3.0093 | 2.7704 |
| Mar 15, 2023 | 2.9302 | 0.1883 | 6.87% | 2.7419 | 2.9302 | 2.6917 |
| Mar 14, 2023 | 2.7715 | -0.1685 | -5.73% | 2.9400 | 2.9400 | 2.6912 |
| Mar 13, 2023 | 3.0191 | -0.5440 | -15.27% | 3.5631 | 3.5731 | 2.9982 |
| Mar 10, 2023 | 3.6238 | 0.0103 | 0.29% | 3.6135 | 3.6634 | 3.5640 |
| Mar 9, 2023 | 3.7131 | -0.2472 | -6.24% | 3.9603 | 4.1786 | 3.5639 |
| Mar 8, 2023 | 3.5246 | -0.0395 | -1.11% | 3.5641 | 3.6041 | 3.4648 |
| Mar 7, 2023 | 3.5148 | -0.0593 | -1.66% | 3.5741 | 3.7130 | 3.5047 |
| Mar 6, 2023 | 3.6437 | 0.0800 | 2.24% | 3.5637 | 3.7130 | 3.5637 |
| Mar 3, 2023 | 3.6436 | 0.1790 | 5.17% | 3.4646 | 3.7723 | 3.4646 |
| Mar 2, 2023 | 3.5146 | 0.0496 | 1.43% | 3.4650 | 3.5546 | 3.4650 |
| Mar 1, 2023 | 3.5346 | 0.0200 | 0.57% | 3.5146 | 3.5645 | 3.4650 |
| Feb 28, 2023 | 3.4750 | 0.1891 | 5.75% | 3.2859 | 3.5248 | 3.2856 |
| Feb 27, 2023 | 3.4157 | -0.2371 | -6.49% | 3.6528 | 3.7229 | 3.3658 |
First Wave BioPharma, Inc. Events
| Tijd (UTC) (UTC) | Land | Evenement |
|---|---|---|
| No events scheduled | ||
- Jaarlijks
- Per kwartaal
| 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|
| Totale inkomsten | 0 | 0 | 0 | 0 | 0 |
| Totale bedrijfskosten | 59.0569 | 26.8313 | 14.7437 | 13.4318 | 10.2212 |
| Verkoop/Algemeen/Admin. Uitgaven, Totaal | 18.3696 | 7.27976 | 6.04227 | 8.17431 | 6.93171 |
| Onderzoek & Ontwikkeling | 38.3204 | 19.105 | 7.85849 | 4.98555 | 2.39548 |
| Depreciation / Amortization | 0.015 | 0.048 | 0.84299 | 0.06191 | 0.754 |
| Other Operating Expenses, Total | 0 | 0.21 | 0.14 | ||
| Bedrijfsresultaat | -59.0569 | -26.8313 | -14.7437 | -13.4318 | -10.2212 |
| Renteopbrengsten (-uitgaven), netto Niet-operationeel | -0.01007 | -5.84013 | -0.43394 | -0.10185 | -0.8752 |
| Overige, Netto | 0.5291 | 0 | |||
| Netto inkomen voor belastingen | -58.5378 | -32.6715 | -15.1777 | -13.5336 | -11.0964 |
| Netto inkomen na belastingen | -58.5378 | -32.6715 | -15.1777 | -13.5336 | -11.0964 |
| Netto inkomen voor extra. Posten | -58.5378 | -32.6715 | -15.1777 | -13.5336 | -11.0964 |
| Netto inkomen | -58.5378 | -32.6715 | -15.1777 | -13.5336 | -11.0964 |
| Inkomsten beschikbaar voor gewone aandelen Excl. Extra. Posten | -84.5186 | -41.7323 | -15.1777 | -13.5336 | -11.0964 |
| Inkomsten beschikbaar voor gewone aandelen Incl. Extra. Posten | -84.5186 | -41.7323 | -15.1777 | -13.5336 | -11.0964 |
| Verwaterd Netto Inkomen | -84.5186 | -41.7323 | -15.1777 | -13.5336 | -11.0964 |
| Verwaterd Gewogen Gemiddelde Aandelen | 8.92573 | 2.84363 | 2.24256 | 1.54393 | 1.06288 |
| Verwaterde Winst per Aandeel Exclusief Buitengewone Posten | -9.4691 | -14.6757 | -6.76803 | -8.76569 | -10.4399 |
| Verwaterde Genormaliseerde Winst per Aandeel | -9.20559 | -14.5356 | -6.76803 | -8.76569 | -10.4399 |
| Inkomsten | 0 | ||||
| Ongebruikelijke uitgaven (inkomsten) | 2.35199 | 0.39857 | |||
| Total Adjustments to Net Income | -25.9807 | -9.06087 |
| Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
|---|---|---|---|---|---|
| Totale inkomsten | 0 | 0 | 0 | 0 | 0 |
| Totale bedrijfskosten | 9.38207 | 11.167 | 30.3995 | 9.27689 | 8.21354 |
| Verkoop/Algemeen/Admin. Uitgaven, Totaal | 4.40556 | 3.03678 | 6.02116 | 3.62809 | 5.69751 |
| Onderzoek & Ontwikkeling | 4.97652 | 5.77821 | 24.3783 | 5.6468 | 2.51503 |
| Depreciation / Amortization | 0.002 | 0.001 | |||
| Bedrijfsresultaat | -9.38207 | -11.167 | -30.3995 | -9.27689 | -8.21354 |
| Renteopbrengsten (-uitgaven), netto Niet-operationeel | -0.00547 | -0.00123 | -0.00074 | -0.00295 | -0.00474 |
| Overige, Netto | -0.2393 | -0.00428 | -0.00057 | 0.0009 | 0.53265 |
| Netto inkomen voor belastingen | -9.62684 | -11.1725 | -30.4008 | -9.27894 | -7.68563 |
| Netto inkomen na belastingen | -9.62684 | -11.1725 | -30.4008 | -9.27894 | -7.68563 |
| Netto inkomen voor extra. Posten | -9.62684 | -11.1725 | -30.4008 | -9.27894 | -7.68563 |
| Netto inkomen | -9.62684 | -11.1725 | -30.4008 | -9.27894 | -7.68563 |
| Total Adjustments to Net Income | -0.68577 | -0.11623 | -0.11809 | -3.45087 | -22.2956 |
| Inkomsten beschikbaar voor gewone aandelen Excl. Extra. Posten | -10.3126 | -11.2887 | -30.5189 | -12.7298 | -29.9812 |
| Inkomsten beschikbaar voor gewone aandelen Incl. Extra. Posten | -10.3126 | -11.2887 | -30.5189 | -12.7298 | -29.9812 |
| Verwaterd Netto Inkomen | -10.3126 | -11.2887 | -30.5189 | -12.7298 | -29.9812 |
| Verwaterd Gewogen Gemiddelde Aandelen | 15.5447 | 12.9223 | 9.34236 | 7.81244 | 5.53481 |
| Verwaterde Winst per Aandeel Exclusief Buitengewone Posten | -0.66342 | -0.87359 | -3.26672 | -1.62943 | -5.41684 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
| Verwaterde Genormaliseerde Winst per Aandeel | -0.66342 | -0.69158 | -3.26672 | -1.62943 | -5.41684 |
| Ongebruikelijke uitgaven (inkomsten) | 2.35199 |
- Jaarlijks
- Per kwartaal
| 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|
| Totaal vlottende activa | 9.42495 | 7.86978 | 3.40829 | 4.8 | 1.95257 |
| Geldmiddelen en kortetermijnbeleggingen | 8.24868 | 6.06214 | 0.1758 | 1.11434 | 0.57347 |
| Cash | 8.24868 | 6.06214 | 0.1758 | 1.11434 | 0.57347 |
| Korte Termijn Investeringen | |||||
| Totale Vorderingen, Netto | 0 | 0.55149 | 2.6373 | 3.17268 | 1.10413 |
| Prepaid Expenses | 1.17627 | 1.25615 | 0.59519 | 0.51298 | 0.27496 |
| Total Assets | 11.79 | 12.9239 | 8.90288 | 7.4694 | 5.47967 |
| Property/Plant/Equipment, Total - Net | 0.40931 | 0.09257 | 0.15978 | 0.12885 | 0.13399 |
| Goodwill, Net | 1.91171 | 2.05405 | 1.88669 | 1.92483 | 2.01624 |
| Intangibles, Net | 0 | 2.87954 | 3.40708 | 0.57048 | 1.34596 |
| Other Long Term Assets, Total | 0.04401 | 0.02792 | 0.04105 | 0.04523 | 0.03092 |
| Total Current Liabilities | 12.3004 | 15.5454 | 4.28564 | 2.99552 | 2.47908 |
| Payable/Accrued | 0 | 0.53343 | 0.6701 | 2.05534 | |
| Accrued Expenses | 0.49706 | 0.18443 | 0.15441 | 0.53829 | 0.00719 |
| Notes Payable/Short Term Debt | 0.64124 | 0.55241 | 1.5213 | 0.25503 | 0.41655 |
| Other Current Liabilities, Total | 8.48018 | 13.25 | 0.39299 | ||
| Total Liabilities | 19.6115 | 15.5646 | 4.28564 | 2.99552 | 3.81908 |
| Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities, Total | 7.31114 | 0.01912 | 0 | 0 | 1.34 |
| Total Equity | -7.82155 | -2.64069 | 4.61724 | 4.47387 | 1.66059 |
| Common Stock | 0.00149 | 0.00312 | 0.00268 | 0.00177 | 0.00121 |
| Additional Paid-In Capital | 147.305 | 93.8349 | 68.5759 | 53.1393 | 37.6696 |
| Retained Earnings (Accumulated Deficit) | -153.904 | -95.3662 | -62.6947 | -47.5171 | -33.9834 |
| Other Equity, Total | -1.22414 | -1.11255 | -1.26656 | -1.15011 | -2.02679 |
| Total Liabilities & Shareholders’ Equity | 11.79 | 12.9239 | 8.90288 | 7.4694 | 5.47967 |
| Total Common Shares Outstanding | 14.8559 | 3.11503 | 2.68005 | 1.77049 | 1.20426 |
| Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | 0 |
| Property/Plant/Equipment, Total - Gross | 0.42402 | 0.13097 | 0.4233 | 0.33225 | |
| Accumulated Depreciation, Total | -0.01471 | -0.0384 | -0.26352 | -0.20339 | |
| Accounts Payable | 2.68191 | 1.55859 | 1.68351 | 1.53211 |
| Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
|---|---|---|---|---|---|
| Totaal vlottende activa | 6.55017 | 9.42495 | 7.50249 | 8.61528 | 13.1704 |
| Geldmiddelen en kortetermijnbeleggingen | 5.69499 | 8.24868 | 7.21065 | 8.07449 | 12.0256 |
| Cash | 5.69499 | 8.24868 | 7.21065 | 8.07449 | 12.0256 |
| Totale Vorderingen, Netto | 0.02806 | 0 | 0 | 0 | 0.50166 |
| Prepaid Expenses | 0.82713 | 1.17627 | 0.29184 | 0.54079 | 0.64313 |
| Total Assets | 8.82544 | 11.79 | 12.424 | 13.7768 | 17.9829 |
| Property/Plant/Equipment, Total - Net | 0.3788 | 0.40931 | 0.44889 | 0.48488 | 0.06162 |
| Property/Plant/Equipment, Total - Gross | 0.40083 | 0.42402 | 0.45632 | 0.4861 | 0.0812 |
| Accumulated Depreciation, Total | -0.02203 | -0.01471 | -0.00743 | -0.00123 | -0.01958 |
| Goodwill, Net | 1.86207 | 1.91171 | 1.94474 | 1.99129 | 1.97396 |
| Intangibles, Net | 0 | 2.48388 | 2.61576 | 2.74765 | |
| Other Long Term Assets, Total | 0.0344 | 0.04401 | 0.04403 | 0.0696 | 0.02924 |
| Total Current Liabilities | 14.2157 | 12.3004 | 19.0983 | 6.45412 | 3.57464 |
| Accounts Payable | 3.44993 | 2.68191 | 18.4478 | 4.44991 | 1.44072 |
| Accrued Expenses | 0.7883 | 0.49706 | 0.22987 | 0.31246 | 0.32383 |
| Notes Payable/Short Term Debt | 0.40277 | 0.64124 | 0 | 0.13957 | 0.34708 |
| Other Current Liabilities, Total | 9.57473 | 8.48018 | 0.42063 | 1.55218 | 1.46302 |
| Total Liabilities | 18.0652 | 19.6115 | 19.394 | 6.73988 | 3.58121 |
| Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities, Total | 3.8495 | 7.31114 | 0.29569 | 0.28575 | 0.00657 |
| Total Equity | -9.23979 | -7.82155 | -6.96999 | 7.03692 | 14.4017 |
| Common Stock | 0.00215 | 0.00149 | 0.00111 | 0.00826 | 0.00749 |
| Additional Paid-In Capital | 155.571 | 147.305 | 137.028 | 120.585 | 118.693 |
| Retained Earnings (Accumulated Deficit) | -163.531 | -153.904 | -142.732 | -112.331 | -103.052 |
| Other Equity, Total | -1.28254 | -1.22414 | -1.26711 | -1.2255 | -1.24734 |
| Total Liabilities & Shareholders’ Equity | 8.82544 | 11.79 | 12.424 | 13.7768 | 17.9829 |
| Total Common Shares Outstanding | 21.5488 | 14.8559 | 11.1152 | 8.25851 | 7.49269 |
| Preferred Stock - Non Redeemable, Net | 0 |
- Jaarlijks
- Per kwartaal
| 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|
| Netto-inkomen/Beginsaldo | -58.5378 | -32.6715 | -15.1777 | -13.5336 | -11.0964 |
| Geldmiddelen uit Operationele Activiteiten | -32.2882 | -11.2215 | -14.0335 | -10.8693 | -7.18464 |
| Geldmiddelen uit Operationele Activiteiten | 0.01471 | 0.0378 | 0.0631 | 0.06191 | 0.04952 |
| Amortization | 0.52755 | 0.52755 | 0.95695 | 0.73654 | 0.70448 |
| Niet-Geldelijke Posten | 8.60641 | 6.73365 | 1.82513 | 3.57765 | 3.42595 |
| Veranderingen in het Operationeel Kapitaal | 17.101 | 14.1509 | -1.70099 | -1.7118 | -0.26821 |
| Geldmiddelen uit Investeringsactiviteiten | -10.3195 | 0.08735 | -0.0241 | -0.30547 | -0.03217 |
| Kapitaaluitgaven | -0.06949 | -0.00417 | -0.0241 | -0.30547 | -0.03217 |
| Geldmiddelen uit Financieringsactiviteiten | 44.7635 | 17.0461 | 13.145 | 11.7121 | 6.01322 |
| Financiering van Cash Flow Posten | 0 | ||||
| Uitgifte (Aflossing) van aandelen, netto | 44.6747 | 14.1861 | 9.53834 | 11.9028 | 5.00923 |
| Uitgifte (Aflossing) van Schulden, Netto | 0.08883 | 2.86003 | 3.60664 | -0.19068 | 1.00399 |
| Wisselkoerseffecten | 0.03076 | -0.02559 | -0.02593 | 0.00354 | 0.00353 |
| Nettowijziging in Geldmiddelen | 2.18654 | 5.88635 | -0.93855 | 0.54087 | -1.20005 |
| Cash Taxes Paid | 0 | 0 | 0 | 0 | |
| Contant Betaalde Rente | 0 | 0.10546 | 0.00803 | 0.00401 | 0.00415 |
| Overige Cash Flow investeringsposten, Totaal | -10.25 | 0.09152 |
| Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
|---|---|---|---|---|---|
| Net income/Starting Line | -9.62684 | -58.5378 | -47.3654 | -16.9646 | -7.68563 |
| Cash From Operating Activities | -7.91207 | -32.2882 | -26.4254 | -10.6961 | -5.07339 |
| Cash From Operating Activities | 0.00732 | 0.01471 | 0.00939 | 0.00301 | 0.00102 |
| Amortization | 0 | 0.52755 | 0.39566 | 0.26377 | 0.13189 |
| Non-Cash Items | 0.36042 | 8.60641 | 2.04186 | 1.7359 | 1.80638 |
| Cash Interest Paid | 0 | 0 | 0 | 0 | 0.00514 |
| Changes in Working Capital | 1.34703 | 17.101 | 18.493 | 4.26576 | 0.67294 |
| Cash From Investing Activities | -10.3195 | -10.3215 | -9.07393 | 0 | |
| Capital Expenditures | -0.06949 | -0.07145 | -0.07393 | 0 | |
| Cash From Financing Activities | 5.36715 | 44.7635 | 37.9406 | 21.8326 | 11.0506 |
| Financing Cash Flow Items | -2.41496 | -9.53235 | |||
| Issuance (Retirement) of Stock, Net | 8.02057 | 44.6747 | 38.493 | 22.2454 | 20.7883 |
| Issuance (Retirement) of Debt, Net | -0.23847 | 0.08883 | -0.55241 | -0.41284 | -0.20532 |
| Foreign Exchange Effects | -0.00877 | 0.03076 | -0.04525 | -0.05019 | -0.01374 |
| Net Change in Cash | -2.5537 | 2.18654 | 1.1485 | 2.01235 | 5.96349 |
| Cash Taxes Paid | 0 | 0 | 0 | ||
| Other Investing Cash Flow Items, Total | -10.25 | -10.25 | -9 |
| Naam investeerder | Type investeerder | Percentage uitstaand | Aandelen in bezit | Wijziging aandelen | Datum bezit | Omzetcijfer |
|---|---|---|---|---|---|---|
| Armistice Capital LLC | Hedge Fund | 2.7101 | 41995 | 41995 | 2022-12-31 | HIGH |
| State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 0.7614 | 11799 | 0 | 2022-12-31 | LOW |
| Sapirstein (James E) | Individual Investor | 0.6914 | 10714 | -32143 | 2023-03-16 | HIGH |
| Acadian Asset Management LLC | Investment Advisor/Hedge Fund | 0.4632 | 7178 | 7178 | 2022-12-31 | MED |
| Romano (Sarah M.) | Individual Investor | 0.3457 | 5357 | -16072 | 2023-03-16 | MED |
| Hoffman (David Andrew) | Individual Investor | 0.2509 | 3888 | -9080 | 2023-03-16 | HIGH |
| Borkowski (Edward J) | Individual Investor | 0.2083 | 3228 | -9080 | 2023-03-16 | LOW |
| Riddell (Alastair) | Individual Investor | 0.1993 | 3089 | -9080 | 2023-03-16 | HIGH |
| Casamento (Charles J) | Individual Investor | 0.1989 | 3082 | -9080 | 2023-03-16 | LOW |
| Coelho (Mary Theresa) | Individual Investor | 0.1953 | 3027 | -9079 | 2023-03-16 | LOW |
| Susquehanna International Group, LLP | Investment Advisor | 0.1408 | 2182 | 2182 | 2022-12-31 | MED |
| UBS Financial Services, Inc. | Investment Advisor | 0.1315 | 2038 | 1752 | 2022-12-31 | LOW |
| Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.0987 | 1529 | 1529 | 2022-12-31 | LOW |
| The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 0.063 | 977 | 0 | 2023-02-28 | LOW |
| Tower Research Capital LLC | Hedge Fund | 0.0626 | 970 | 497 | 2022-12-31 | HIGH |
| BlackRock Institutional Trust Company, N.A. | Investment Advisor | 0.0243 | 377 | 0 | 2022-12-31 | LOW |
| Advisor Group, Inc | Investment Advisor | 0.0185 | 286 | 286 | 2022-12-31 | LOW |
| Wells Fargo Advisors | Research Firm | 0.0017 | 27 | 0 | 2022-12-31 | LOW |
| U.S. Bancorp Asset Management, Inc. | Investment Advisor | 0.0015 | 24 | 0 | 2022-12-31 | LOW |
| BlackRock Financial Management, Inc. | Investment Advisor/Hedge Fund | 0.0014 | 22 | 0 | 2022-12-31 | LOW |
Waarom Capital.com? De cijfers spreken voor zichzelf.
Capital.com Group500K+
Handelaren
92K+
Actieve klanten per maand
$53M+
Maandelijks beleggingsvolume
$30M+
Opgenomen per maand
Handelscalculator
Bereken uw virtuele winst- en verliesrekening indien u een CFD-positie had geopend op een bepaalde datum (kies een datum) en gesloten op een andere datum (kies een datum).
Handelscommissie
0
- 1:1
Hefboom
1:1
- 20
- 100
- 500
- 1000
- 10000
Investering
Positiegrootte (hefboomwerking x investering):
Openingskoers
Slotkoers
Short Long
First Wave BioPharma, Inc. Company profile
Over First Wave BioPharma, Inc.
First Wave BioPharma, Inc., voorheen AzurRx BioPharma, Inc., is een biofarmaceutisch bedrijf in een klinische fase. Het houdt zich bezig met de ontwikkeling van doelgerichte, niet-systemische therapieën voor gastro-intestinale (GI) ziekten. Het bedrijf richt zich op de ontwikkeling van een therapeutische ontwikkelingspijplijn die is opgebouwd rond zijn twee technologieën: niclosamide, een oraal klein molecuul met antivirale en ontstekingsremmende eigenschappen, en het biologische adrulipase, een recombinant lipase-enzym dat is ontwikkeld om de vertering van vetten en andere voedingsstoffen mogelijk te maken. De niclosamideportefeuille van de Vennootschap wordt aangevoerd door drie klinische programma's: FW-COV, voor COVID-19 gastro-intestinale infecties; FW-UP, voor ulceratieve proctitis (UP) en ulceratieve proctosigmoiditis; en FW-ICI-AC, voor graad 1 en graad 2 immuuncheckpointinhibitor-geassocieerde colitis en diarree bij gevorderde oncologiepatiënten. Het bedrijf is ook bezig met de ontwikkeling van FW-EPI (adrulipase) voor de behandeling van exocriene pancreasinsufficiëntie (EPI) bij patiënten met cystische fibrose en chronische pancreatitis.
| Industry: | Biotechnology & Medical Research (NEC) |
777 Yamato Road
Suite 502
BOCA RATON
FLORIDA 33431
US
Winst- en verliesrekening
- Annual
- Quarterly
Mensen bekijken ook
Nog steeds op zoek naar een broker die u kunt vertrouwen?
Sluit u aan bij de 500.000+ handelaren die er wereldwijd voor kozen om met Capital.com te handelen